Intensity Therapeutics Inc. (INTS)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
3. 35
-0.03
-0.8876%
$
9.05M Market Cap
- P/E Ratio
- Div Yield
32,300 Volume
-0.92 Eps
$ 3.38
Previous Close 
Want to track INTS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Intensity Therapeutics Inc. (INTS) Statistics
Valuation metrics
Market Cap 9.05M
Enterprise value -379.55K
Trailing P/E (ttm) -0.69
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.98
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.03
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 35.66K
Average volume (90 days) 26.8K
Price summary
52-Week low 3.1
52-Week high 43.5
Beta -
50-Day moving average 3.78
200-Day moving average 4.41
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 19 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.97%
Return on equity -1.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.52
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5%
Book value per share (mrq) 3.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
